Stock Research: Bachem

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Bachem

SWX:BANB CH1176493729
25
  • Value
    92
  • Growth
    23
  • Safety
    Safety
    34
  • Combined
    57
  • Sentiment
    8
  • 360° View
    360° View
    25
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Bachem Holding AG is a biochemical company providing services to the pharmaceutical and biotechnology industries. It focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs). It operates under the Bachem and Clinalfa brands. The company operates in Switzerland and the United States. In the last fiscal year, the company had a market cap of $5,320 million, profits of $201 million, and revenue of $667 million, with 2207 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 25 (better than 25% compared with alternatives), overall professional sentiment and financial characteristics for the stock Bachem are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four metrics below average for Bachem. The only rank that is above average is the consolidated Safety Rank at 92, which means that the company has a financing structure that is safer than those of 92% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the Value, Growth and Sentiment Ranks are all below average. The consolidated Value Rank has a less desirable rank of 34, which means that the share price of Bachem is on the high side compared with typical size in indicators such as revenues, profits, and invested capital. The consolidated Growth Rank also has a low rank of 23, which implies that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. Finally, the consolidated Sentiment Rank is also low at a rank of 8, which means that professional investors are more pessimistic about the stock than for 92% of alternative investment opportunities. While Safety is strong, it’s not the most critical indicator, so we suggest proceeding with caution if you are considering this stock. ...read more

more
Index
SDG 12
SDG 3
SDG 4
SDG 8
SPI
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
34 47 45 35
Growth
23 24 83 99
Safety
Safety
92 100 98 90
Sentiment
8 75 13 12
360° View
360° View
25 85 82 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
18 5 1 17
Opinions Change
14 62 75 26
Pro Holdings
n/a 80 53 72
Market Pulse
47 87 4 38
Sentiment
8 75 13 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
34 47 45 35
Growth
23 24 83 99
Safety Safety
92 100 98 90
Combined
57 78 100 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
34 33 30 11
Price vs. Earnings (P/E)
9 13 17 28
Price vs. Book (P/B)
30 40 37 13
Dividend Yield
63 72 63 61
Value
34 47 45 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
92 75 80 75
Profit Growth
25 42 56 78
Capital Growth
16 11 95 86
Stock Returns
21 37 35 95
Growth
23 24 83 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
94 95 96 49
Refinancing
53 60 59 96
Liquidity
98 100 100 96
Safety Safety
92 100 98 90

Similar Stocks

Discover high‑ranked alternatives to Bachem and broaden your portfolio horizons.

ALSO

SWX:ALSN
Country: Switzerland
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

SoftwareONE Holding

SWX:SWON
Country: Switzerland
Industry: Technology Distributors
Size: Medium
Full Stock Analysis

Perrigo

NYSE:PRGO
Country: Ireland
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.